Ventana Biotech, Inc.
VNTA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.7M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.70 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -3.53 |
| Outstanding Shares | 53,783,544 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 19.75 |
|---|---|
| PEG | -30.86 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ventana Biotech, Inc.
1 employees
CEO: Stephen Replin
Ventana Biotech, Inc. is an emerging biotechnology enterprise focused on the lifecycle of drug candidates for personalized medicine, encompassing the identification, assessment, acquisition, development, and eventual commercialization th...